Relationship between the BRAF V600E and tumor size, lymph node, and distant metastasis in papillary thyroid carcinoma
Aim – This study aimed to analyze the association between B-Raf proto-oncogene, serine/threonine kinase (BRAF) V600E and tumor size, lymph node, and distant metastasis (TNM) status on patients with papillary thyroid carcinoma. Material and Methods – This research is a cross-sectional study. A total...
Saved in:
| Main Authors: | Edmond Rukmana Wikanta, Yan Wisnu Prajoko, Benny Issakh, Hermawan Istiadi, Dik Puspasari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Limited liability company «Science and Innovations» (Saratov)
2022-06-01
|
| Series: | Russian Open Medical Journal |
| Subjects: | |
| Online Access: | https://romj.org/node/458 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
by: Jennifer A. Silver, et al.
Published: (2021-11-01) -
Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review
by: Shingo FUJIO, et al.
Published: (2025-05-01) -
Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the <i>BRAF</i> p.V600E Mutation in a Subset of Cases
by: Feifan Chen, et al.
Published: (2024-06-01) -
A combined model integrating deep learning, radiomics, and clinical ultrasound features for predicting BRAF V600E mutation in papillary thyroid carcinoma with Hashimoto’s thyroiditis
by: Peng-Fei Zhu, et al.
Published: (2025-08-01) -
High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024-11-01)